ATE269858T1 - Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan - Google Patents
Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartanInfo
- Publication number
- ATE269858T1 ATE269858T1 AT00126032T AT00126032T ATE269858T1 AT E269858 T1 ATE269858 T1 AT E269858T1 AT 00126032 T AT00126032 T AT 00126032T AT 00126032 T AT00126032 T AT 00126032T AT E269858 T1 ATE269858 T1 AT E269858T1
- Authority
- AT
- Austria
- Prior art keywords
- losartan
- crystalline
- acid addition
- addition salt
- purifying
- Prior art date
Links
- 239000002083 C09CA01 - Losartan Substances 0.000 title abstract 5
- KJJZZJSZUJXYEA-UHFFFAOYSA-N losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 title abstract 5
- 229960004773 losartan Drugs 0.000 title abstract 5
- 239000002253 acid Substances 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34682999 | 1999-12-06 | ||
| JP2000282853A JP2001226372A (ja) | 1999-12-06 | 2000-09-19 | ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE269858T1 true ATE269858T1 (de) | 2004-07-15 |
Family
ID=26578371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00126032T ATE269858T1 (de) | 1999-12-06 | 2000-11-29 | Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6350880B1 (de) |
| EP (1) | EP1106611B1 (de) |
| JP (1) | JP2001226372A (de) |
| AT (1) | ATE269858T1 (de) |
| DE (1) | DE60011739T2 (de) |
| ES (1) | ES2218051T3 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2482857A1 (en) * | 2002-04-29 | 2003-11-13 | Teva Pharmaceutical Industries Ltd. | Processes for preparing losartan and losartan potassium |
| RU2305092C2 (ru) * | 2002-05-09 | 2007-08-27 | Инститьют Оф Материя Медика, Чайниз Экедеми Оф Медикал Сайенсез | НОВЫЕ 2-(α-ГИДРОКСИПЕНТИЛ)БЕНЗОАТЫ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ |
| SI1589966T1 (sl) * | 2003-01-30 | 2011-06-30 | Lek Pharmaceuticals D.D. | Postopek čiščenja losartana |
| CA2589146C (en) * | 2004-12-14 | 2011-09-20 | Kyorin Pharmaceutical Co., Ltd. | Process for producing muscarine receptor antagonist and intermediate therefor |
| TWI358407B (en) * | 2005-06-22 | 2012-02-21 | Lundbeck & Co As H | Crystalline base of escitalopram and orodispersibl |
| ATE528305T1 (de) * | 2007-08-08 | 2011-10-15 | Lek Pharmaceuticals | Verfahren zur herstellung oder reinigung von olmesartan-medoxomil oder von olmesartan- medoxomil-hydrohalid-salz |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA875052B (en) * | 1986-07-11 | 1989-03-29 | Du Pont | Angiotensin ii receptor blocking imidazoles |
| US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| CA2123900C (en) | 1991-11-18 | 1998-07-14 | Young Sek Lo | Tetrazolylphenylboronic acid intermediates for the synthesis of aii receptor antagonists |
| US5464854A (en) * | 1993-11-11 | 1995-11-07 | Depadova; Anathony S. | Method of modifying ovarian hormone-regulated AT1 receptor activity as treatment of incapacitating symptom(s) of P.M.S. |
| CA2179067A1 (en) | 1993-12-23 | 1995-06-29 | Gordon Creston Campbell, Jr. | Polymorphs of losartan and the process for the preparation of form ii of losartan |
| JP3249827B2 (ja) | 1996-10-29 | 2002-01-21 | メルク エンド カンパニー インコーポレーテッド | ロサルタンの結晶化法 |
| IT1301759B1 (it) | 1998-06-19 | 2000-07-07 | Nicox Sa | Sali nitrati di farmaci antiipertensivi |
-
2000
- 2000-09-19 JP JP2000282853A patent/JP2001226372A/ja active Pending
- 2000-11-16 US US09/714,339 patent/US6350880B1/en not_active Expired - Fee Related
- 2000-11-29 AT AT00126032T patent/ATE269858T1/de not_active IP Right Cessation
- 2000-11-29 DE DE60011739T patent/DE60011739T2/de not_active Expired - Lifetime
- 2000-11-29 ES ES00126032T patent/ES2218051T3/es not_active Expired - Lifetime
- 2000-11-29 EP EP00126032A patent/EP1106611B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001226372A (ja) | 2001-08-21 |
| EP1106611B1 (de) | 2004-06-23 |
| US6350880B1 (en) | 2002-02-26 |
| DE60011739D1 (de) | 2004-07-29 |
| DE60011739T2 (de) | 2005-09-01 |
| EP1106611A1 (de) | 2001-06-13 |
| ES2218051T3 (es) | 2004-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60336326D1 (de) | Verfahren zur herstellung des calciumsalzes von rosuvastatin | |
| BRPI0412763A (pt) | formas anidras, hidratadas ou solvatadas de um composto, forma cristalina, composição farmacêutica, e, método para o tratamento ou a profilaxia de distúrbios | |
| ATE168007T1 (de) | Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole | |
| DE60221619D1 (de) | Verfahren zur Reinigung von Synthesegas | |
| DE60126099D1 (de) | Kristallines und reines modafinil und verfahren zu seiner herstellung | |
| ATE310009T1 (de) | Reaktionssysteme zur herstellung von n- (phosphonomethyl)glyzin verbindungen | |
| DE60114348D1 (de) | Verfahren zur Reinigung von Gasen | |
| DE60208221D1 (de) | Heterozyklische verbindungen zur behandlung von harnwegserkrankungen | |
| NL300229I2 (nl) | Werkwijze voor het zuiveren van keratinocytgroeifactoren. | |
| DE60228317D1 (de) | N-aryl-n'-arylcycloalkyl-harnstoff als mch antagonisten zur behandlung von fettleibigkeit | |
| ATE388135T1 (de) | Verfahren zur herstellung von 1,3-substituierte indene und aryl-annellierte azapolycyclische verbindungen | |
| ATE449104T1 (de) | Verfahren zur reinigung von fibrinogen | |
| NO20013941D0 (no) | Polynukleotider med forkortet kjede og fremgangsmate ved fremstillingen derav | |
| DE60132637D1 (de) | Verfahren zur herstellung von pyrimidinonverbindungen und deren pharmazeutisch unbedenklichen salzen | |
| ATE269858T1 (de) | Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan | |
| DE60316791D1 (de) | Verfahren zur aufreinigung von lanzoprazol | |
| ID26210A (id) | Proses pemurnian turunan sefalosporin | |
| DE50300917D1 (de) | Anlagenteil und verfahren zur zerlegung und reinigung von synthesegas | |
| ATE481408T1 (de) | Reinigung von beta-lactam-verbindungen | |
| WO2004075860A3 (en) | Process for purification of zoledronic acid | |
| ATE459599T1 (de) | Gereinigtes lasofoxifen und verfahren zur aufreinigung von racemischem lasofoxifen durch umkristallisieren | |
| DE50010234D1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
| DE60315545D1 (de) | Verfahren zur Reinigung von geschützten 2'-Deoxycytidine | |
| DE60001683D1 (de) | Verfahren zur Reinigung von 3,7,11,15-Tetramethyl-2,4,6,10,14-hexadecapentaenonsäure | |
| DE60311809D1 (de) | Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |